Venture Capital Firms

Investing in innovative startups for a better future.

SVTech funds and connects early stage tech startups with open innovation needs of our strategic LPs and corporate partners, mostly $10B+ tech companies with global markets including Lenovo, Xiaomi and holding companies like Legend Holdings. We also work closely with US brand name VC firms and CVCs, such as Formation 8 and Intel Capital, to co-invest in emerging technologies and accelerate their global adoption.

Investing in high-growth technology companies.

Supporting early-stage IT startups in Russia.

Investisseurs & Partenaires (I&P) is an impact investment group established in 2002, focused on financing and supporting small and medium-sized enterprises (SMEs) and start-ups in Sub-Saharan Africa. Managed by Jean-Michel Severino since 2011, I&P has built a strong reputation in impact investing, operating from Paris, Washington D.C., and ten African offices. The organization manages two main funds, IPDEV and IPAE, which provide diverse investment options including equity and quasi-equity financing. I&P's mission is to foster the growth of African SMEs by offering long-term financing, strategic and technical support, and managerial assistance. The organization targets companies with high local value and growth potential, particularly in sectors like agriculture, education, and sustainable resource management. With a portfolio of over 350 SMEs across 15 African countries and a total capital raised of €480 million, I&P is committed to promoting sustainable entrepreneurship and contributing to the development of a robust entrepreneurial ecosystem in Africa.

Investing in the future of AI and advanced technologies.

Accelerating clean mobility innovation in India.

Transforming healthcare investment across borders.

Novax is a Sweden-based investment company that invests in small and medium-sized growth companies in health and wellness, technical security and retail sectors.

Investing in the future for positive impact.

Poalim Equity is the investment platform of Bank Hapoalim, Israel's largest financial institution. Established in 1990 and headquartered in Tel Aviv, it operates as a leading merchant bank, providing a wide range of private equity, venture capital, and investment banking services. The firm employs around 130 to 200 professionals and offers end-to-end financial solutions tailored to innovative and growth-stage companies across various sectors. The company specializes in direct equity investments, mergers and acquisitions advisory, and complex capital solutions, including mezzanine financing and growth capital. Poalim Equity also manages a real estate fund focused on assets in Eastern Europe and Israel. With a strong emphasis on Israeli-related companies, it targets sectors such as high technology, fintech, health tech, and pharmaceuticals. Poalim Equity serves startups, mature businesses, and global fund managers, facilitating cross-border transactions through its partnership with William Blair.

Empowering sports ventures through capital and community.

Investing in visionary founders and transformative technology.

Investing in visionary founders and innovative technologies.

Empowering Innovation in Core Industries

Empowering early-stage founders to build innovative companies.

Empowering transformative founders.

Investing in life sciences for over 50 years.

Transforming science into breakthrough medicines.

明天控股有限公司成立于1999年，是国内最早从事股权投资的公司之一，也是国内投资行业的骨干力量，致力于打造受尊敬的、可持续发展的全球投资机构。明天控股公司总部设于北京，在上海、山东、内蒙、辽宁、江苏、广东等十几个区域都建立了分支机构，如今已发展为横跨金融、实业、地产、通讯服务、能源、互联网等多个领域，资产规模庞大的控股集团。专业缔造价值，稳健支撑发展。现代经济运行证明，高科技和现代金融将是未来经济发展的两大动力。明天控股的核心优势在于其多年行业经验积累的资源整合能力和在市场变化中锻炼出的应变和创新能力。在未来的发展中，集团将继续发挥这一专业优势，将成长的价值分享给更多的伙伴，坚守"最大限度无风险投资"的理念，理性务实，保障集团稳健、健康发展。人才是企业发展之本，创新是企业发展之魂。作为智慧密集型企业，明天控股汇聚了各行各业的高端人才，并真正实现了对员工不抛弃、不放弃，搭建发展平台，与员工共同成长。在发展过程中，集团始终坚持时时刻刻对外学习的理念，以全球视野，创新思维，打造出了一支踏实进取、敢想敢干的精英团队，建立了一个低调稳健、谦恭儒雅的企业集团。今日挑战极限，明天创造辉煌。明天集团以"创新、责任、包容、共赢"为核心价值观，纳百川、融细流，以感恩之心做民族事业，承担起企业公民应尽的责任和义务，服务社区，保障就业，共赢明天。

Transforming healthcare for aging populations.

Investing in AI-driven health technology.

Investing in underestimated founders.